Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Cash Flow Conversion Efficiency
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥26.54 Million ≈ $3.88 Million USD) by net assets (CN¥1.69 Billion ≈ $246.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
Cash flow conversion efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. This chart illustrates how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shaanxi Panlong Pharmaceutical Group Lim (002864) share price today for real-time trading data and today's change.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Cash Flow Conversion Ratio Explained
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A ranked by their cash flow conversion efficiency. Also see Shaanxi Panlong Pharmaceutical Group Lim market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
cBrain A/S
CO:CBRAIN
|
0.133x |
|
Yuen Foong Yu Consumer Prod
TW:6790
|
0.071x |
|
BH Co Ltd
KQ:090460
|
0.352x |
|
Haymaker Acquisition Corp. 4
NYSE:HYAC
|
-0.215x |
|
Seanergy Maritime Holdings Corp
NASDAQ:SHIP
|
0.101x |
|
ADF Foods Limited
NSE:ADFFOODS
|
0.056x |
|
Picpay Holdings Netherlands N.V. Class A Common Shares
NASDAQ:PICS
|
0.736x |
|
Fiverr International Ltd
NYSE:FVRR
|
0.032x |
Annual Cash Flow Conversion Efficiency for Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (2013–2025)
The table below shows the annual cash flow conversion efficiency of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A from 2013 to 2025. Review 002864 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.69 Billion ≈ $247.16 Million |
CN¥63.01 Million ≈ $9.22 Million |
0.037x | -61.00% |
| 2024-12-31 | CN¥1.64 Billion ≈ $239.57 Million |
CN¥156.59 Million ≈ $22.91 Million |
0.096x | +42.60% |
| 2023-12-31 | CN¥1.55 Billion ≈ $227.00 Million |
CN¥104.05 Million ≈ $15.23 Million |
0.067x | -49.30% |
| 2022-12-31 | CN¥947.60 Million ≈ $138.66 Million |
CN¥125.36 Million ≈ $18.34 Million |
0.132x | -7.97% |
| 2021-12-31 | CN¥807.21 Million ≈ $118.12 Million |
CN¥116.04 Million ≈ $16.98 Million |
0.144x | +14.65% |
| 2020-12-31 | CN¥735.66 Million ≈ $107.65 Million |
CN¥92.24 Million ≈ $13.50 Million |
0.125x | +24.61% |
| 2019-12-31 | CN¥674.71 Million ≈ $98.73 Million |
CN¥67.89 Million ≈ $9.93 Million |
0.101x | +31.36% |
| 2018-12-31 | CN¥611.60 Million ≈ $89.50 Million |
CN¥46.85 Million ≈ $6.86 Million |
0.077x | +49.58% |
| 2017-12-31 | CN¥555.58 Million ≈ $81.30 Million |
CN¥28.45 Million ≈ $4.16 Million |
0.051x | -72.92% |
| 2016-12-31 | CN¥327.82 Million ≈ $47.97 Million |
CN¥61.99 Million ≈ $9.07 Million |
0.189x | +34.49% |
| 2015-12-31 | CN¥288.89 Million ≈ $42.27 Million |
CN¥40.62 Million ≈ $5.94 Million |
0.141x | -28.71% |
| 2014-12-31 | CN¥246.19 Million ≈ $36.03 Million |
CN¥48.56 Million ≈ $7.11 Million |
0.197x | +63.50% |
| 2013-12-31 | CN¥210.84 Million ≈ $30.85 Million |
CN¥25.43 Million ≈ $3.72 Million |
0.121x | -- |
About Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chine… Read more